Skip to content

ghk-cu

GHK-Cu research: what it has been studied for, in plain English

Research overview 8 min read

On this page
  1. What is GHK-Cu?
  2. What does GHK-Cu do?
  3. Research areas at a glance
  4. How is it thought to work?
  5. What kind of studies are these?
  6. Sources

GHK-Cu is a small copper-binding peptide, three amino acids holding a copper ion, and in research it has mainly been studied for how fibroblasts (collagen-making cells) produce collagen in lab dishes and how connective tissue builds up in rat wound chambers [G3, G5, G6]. Researchers have also measured how the peptide binds copper and whether it moves copper into cells [G3, G4]. GHK, the same peptide without copper, has been looked at in computer analyses of gene activity [G10]. Most of this work is cell and animal research [G2].

What is GHK-Cu?

A peptide is a short chain of amino acids, the building blocks of proteins. GHK is a tripeptide, a chain of three: glycine, histidine and lysine, giving the full name glycyl-L-histidyl-L-lysine [G4]. GHK-Cu is GHK bound to a copper ion [G4]. Older papers write the peptide as GHL [G3].

It was isolated from human plasma, the liquid part of blood [G3, G5]. There it came out together with roughly equal amounts of copper [G3].

Not every study tests the same molecule. Some use GHK without copper, and some use related copper peptides. A 2026 evidence-mapping review by Mateescu et al. cautions that GHK, GHK-Cu and related copper peptides are not interchangeable [G2], so this post names the molecule each study tested.

What does GHK-Cu do?

In research, GHK-Cu has mainly been studied in lab dishes and in rats, looking at how cells and tissue respond to it. The research areas, in plain terms:

  • Collagen made by fibroblasts, the cells that make collagen, the main structural protein of skin, in lab dishes [G5], and how fast those cells grow and which growth factors they release [G7].
  • Connective tissue in small rat wounds: how much built up in mesh chambers placed under rats' skin [G6].
  • Skin-surface cells: how keratinocytes, the main cells of the skin's outer layer, grew in lab-grown skin [G8].
  • Copper binding: how GHK holds copper and whether it moves copper into cells [G3, G4].
  • Hair-follicle models: the lab study here tested AHK-Cu (alanyl-histidyl-lysine copper), a related copper peptide, not GHK-Cu [G9].
  • Gene-activity patterns: a computer comparison with damaged lung tissue, then GHK without copper in lung cells [G10].

Research areas at a glance

Area What researchers looked at Models How strong the evidence is
Wound and skin models How much collagen and other connective tissue built up in small wounds [G6]; how skin-surface cells grew and which markers they showed [G8] Mesh wound chambers under the skin of rats [G6]; human keratinocytes and lab-grown skin equivalents [G8] Animal and lab studies [G6, G8]
Fibroblasts and collagen Collagen production by cultured fibroblasts [G5]; growth rate and growth-factor output of normal and previously irradiated human skin fibroblasts [G7] Cultured fibroblasts [G5]; primary human skin fibroblasts [G7] Cell studies only [G5, G7]
Copper transport How GHK binds copper, whether it competes with albumin (the blood's main copper-carrying protein) for it, and whether it moves copper into cells [G3, G4] Chemistry experiments [G4]; cultured liver-cancer cells [G3] Chemistry and cell studies; a role in the body was proposed, not shown [G3, G4]
Hair-follicle models Follicle length, and growth of dermal papilla cells, which sit at the base of the follicle [G9] Human hair follicles kept alive in the lab; cultured dermal papilla cells. Tested AHK-Cu, a related copper peptide [G9] Lab studies of a related compound [G9]
Gene expression (Connectivity Map) Whether GHK's gene-activity pattern ran opposite to a lung-damage signature, then a follow-up in lung cells [G10] Computer matching against a public cell-response library; human lung fibroblasts given GHK without copper [G10] Computational and cell work; the Mateescu review called it hypothesis-generating [G2]

Evidence levels follow the sources; Mateescu et al. graded human, animal, cell and gene-data evidence separately [G2].

How is it thought to work?

Mateescu et al.'s review described the preclinical (cell and animal) data as consistently supporting effects on matrix remodelling (the rebuilding of the material between cells), epithelial repair (repair of the epithelium, the cell layer that lines body surfaces), inflammatory and redox (oxidative-stress) regulation, and angiogenesis, the growth of new blood vessels, while finding the clinical evidence sparse [G2].

Every finding below comes from chemistry, cells, tissue kept alive in the lab, rat wound chambers or computer analysis.

Copper carrier hypothesis. In GHK, histidine sits next to a basic (positively charged) amino acid, a layout resembling the copper-binding sites on albumin [G3]. In equilibrium dialysis, a test where molecules compete for copper across a membrane, the peptide competed with albumin for copper [G4]. It readily formed complexes with copper and increased copper uptake into cultured hepatoma (liver-cancer) cells [G3]. Pickart's group suggested it "may act as a copper transport factor" [G3], and Lau and Sarkar discussed a possible role moving copper from blood to tissues [G4]. Both are proposals, made from test-tube and cell work [G3, G4].

Collagen and matrix signals. In cultured fibroblasts, GHK-Cu increased collagen synthesis independent of any change in cell number [G5]. In the rat wound chambers, Maquart et al. compared it with saline and with a control tripeptide (Glu-His-Pro) that had no significant effect [G6]. They measured concentration-dependent increases in total protein, collagen and glycosaminoglycans, sugar-chain molecules in connective tissue [G6]. Messenger RNA (mRNA, a gene's working copy) for type I and III collagen rose, while mRNA for TGF-β, a growth factor that drives collagen production, did not [G6]. Human skin fibroblasts, normal and from previously irradiated skin, grew faster with GHK-Cu than control cells without it, and the irradiated cells made more bFGF and VEGF (growth factors for cells and blood vessels) early on [G7]. Because GHK's sequence occurs in type I collagen, the Reims group suggested it "might be liberated by proteases at the site of a wound" [G5]; proteases are enzymes that cut proteins.

Skin-cell markers. In cultured keratinocytes, GHK-Cu increased proliferation (cell multiplication) [G8]. In lab-grown skin, basal cells (the bottom layer) became cuboidal, and several markers rose: PCNA, a marker of dividing cells; p63, a marker associated with skin stem cells; and integrins α6 and β1, proteins that anchor cells to the tissue around them [G8].

Follicle cells (AHK-Cu). Pyo et al. tested AHK-Cu, not GHK-Cu. It lengthened human hair follicles kept alive outside the body (ex vivo) and increased proliferation of cultured dermal papilla cells [G9]. Markers of apoptosis (programmed cell death) shifted, but the drop in apoptotic cells was not statistically significant [G9].

Gene expression. Campbell et al. profiled lung tissue from 8 smokers with COPD (64 samples) and found 127 genes whose activity tracked emphysema severity [G10]. They searched the Connectivity Map, a public library of how cultured cells' gene activity shifts after exposure to many compounds. GHK's pattern ran opposite to the severity signature and resembled TGF-β pathway activation [G10]. In follow-up work, GHK without copper in human lung fibroblasts reproduced TGF-β-like expression patterns, organised the actin cytoskeleton (the cell's internal scaffolding) and raised integrin β1 [G10]. Pickart and Margolina wrote that the copper hypothesis is "still valid" but, in their view, "doesn't explain the gene modulating effects of GHK-Cu", and proposed that Connectivity Map data show GHK raising and lowering the activity of many genes [G1]. The Mateescu review calls Connectivity Map findings "hypothesis-generating" [G2].

What kind of studies are these?

Chemistry experiments look at molecules in a test tube. Cell studies (in vitro) use cells in a dish; ex vivo studies use human tissue kept alive outside the body. Animal studies use living animals such as rats, and computational studies look for patterns in existing gene data. Human (clinical) studies involve people; in randomised controlled trials, people are assigned by chance to groups that are then compared.

GHK-Cu's evidence sits almost entirely in chemistry, cell and rat work. Mateescu et al. searched PubMed, Europe PMC, ClinicalTrials.gov and other sources up to 12 August 2026, and described the clinical evidence as "sparse" [G2].

The human studies are small or incompletely described cosmetic studies; the review gives participant numbers for two of them, 13 who completed one study and 18 in the other [G2]. In the first, adults who had CO₂ laser resurfacing were randomly assigned to a study product with or without GHK-Cu, and redness and other objective skin measures were assessed by computer analysis and by blinded evaluators, who did not know each person's group [G2, G11]. A phase 2 trial involving skin wounds is registered (NCT07437586) and was listed as recruiting, with no results, as of August 2026 [G2].

One note on authorship. The 2018 review by Pickart and Margolina lists both authors' affiliation as R&D Skin Biology, and declares no conflict of interest [G1]. Pickart, its first author, also co-authored the 1980 plasma study and the 1988 fibroblast study [G1, G3, G5]. This post uses that review only for its authors' gene-expression proposal, and leans on the other studies cited here and on the 2026 review, which is independent of that group [G2].

For the same kind of map of another research peptide, see how the BPC-157 research is laid out. Back to the Limitless Science home page.

Sources

All products are sold for laboratory research use only. Not for human or veterinary use. Nothing on this page is medical advice.

Keep reading